A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III)
Type of Publication
Journal Article
Year of Publication
2019
Journal
International Journal of Stroke
DOI
10.1177/1747493019839280
Language
Eng
Links to full text